Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Expanding Adoption of Single-Use Systems Drives Need for Wider Range of Sterile Connector Technologies
James Barry, Director of Marketing, Americas, Pall Biotech
Overcoming Obstacles in AAV Viral Vector Manufacturing
Choice of Upstream Bioreactor Technologies for Industrial Scale Viral Manufacturing (White Paper USD3244)
Pall Corporation
Characterization and Engineering Performance of the Allegro™ STR 500 Single-Use Stirred Tank Bioreactor
View All Featured ArticlesHeadline News
Pfizer’s 25-valent pneumococcal vaccine shows robust immune responses in Phase II infant study
Jemperli achieves 76% complete response rate in Phase II rectal cancer trial
Mo-Rez shows 62% response rate in platinum-resistant ovarian cancer
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
From Early Stage to Late Stage Development: How to Characterize a Perfusion-based Vaccine Production Process Using QbD?
Presented by Perrine Rouel, Scientist - Up Stream Processing, The Janssen Pharmaceutical Companies of Johnson & Johnson and Tom Jeffery, Application Specialist – Ambr Technology KAM Europe at Sartorius Stedim Biotech
27th March 2019
In Situ High Speed NIR Imaging & Raman Mapping to Monitor Form Change and Drug Release from Rapidly Disintegrating Tablets
Presented by Patrick Wray, Senior Research Investigator at Bristol-Myers Squibb and Miriam Böhmler, Senior Applications Scientist at WITec GmbH
10th March 2020
Points to consider when defining a microbial control strategy for individualized ATMPs
Presented by Friedrich von Wintzingerode, PhD, QC Lead iNeST Project (individualized Neoantigen Specific Therapy)
05th April 2023
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Rationale Design of Valves for Flexible Processing
Column Packing Protocol for Amsphere A3
Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
